The University of Chicago Header Logo

Connection

Jozef Madzo to Precursor Cell Lymphoblastic Leukemia-Lymphoma

This is a "connection" page, showing publications Jozef Madzo has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
  1. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study. Cancer. 2003 Jan 01; 97(1):105-13.
    View in: PubMed
    Score: 0.166
  2. ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia. Blood. 2011 Jan 06; 117(1):368-9; author reply 370-1.
    View in: PubMed
    Score: 0.072
  3. Prenatal origin of childhood AML occurs less frequently than in childhood ALL. BMC Cancer. 2006 Apr 21; 6:100.
    View in: PubMed
    Score: 0.052
  4. TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL. Leukemia. 2005 Jul; 19(7):1296-7.
    View in: PubMed
    Score: 0.049
  5. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens. BMC Cancer. 2005 Apr 12; 5:38.
    View in: PubMed
    Score: 0.048
  6. TEL/AML1 and immunoreceptor gene rearrangements-which comes first? Leuk Res. 2005 Jun; 29(6):633-9.
    View in: PubMed
    Score: 0.048
  7. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells. Leukemia. 2004 Mar; 18(3):434-41.
    View in: PubMed
    Score: 0.045
  8. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type. J Virol. 2018 09 15; 92(18).
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.